Literature DB >> 8380074

TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein.

Y S Kim1, R Risser.   

Abstract

Tat is a transactivator of human immunodeficiency virus type 1 (HIV-1) that stimulates gene expression via an RNA target sequence (TAR) by augmenting transcriptional initiation and/or elongation from the HIV-1 long terminal repeat promoter. Here we show that Tat is able to transactivate the murine cytomegalovirus (MCMV) major immediate-early promoter (MIEP), which lacks sequence similarity with the HIV-1 long terminal repeat TAR element. Surprisingly, deletion of the upstream enhancer region (-610 to -146) of the MCMV MIEP abrogated Tat responsiveness. This result suggests that Tat requires a DNA target for function. Quantitation of RNA and protein indicates that Tat stimulates expression from the MCMV MIEP at both the transcriptional and translational levels. Deletion analysis of the MIEP indicates that there is likely to be interplay between the enhancer region, a sequence upstream of the known enhancer which negatively affects expression, and the Tat protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380074      PMCID: PMC237357     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.

Authors:  R Gentz; C H Chen; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes.

Authors:  M A Albrecht; N A DeLuca; R A Byrn; P A Schaffer; S M Hammer
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

4.  Translational control of SV40 T antigen expressed from the adenovirus late promoter.

Authors:  C Thummel; R Tjian; S L Hu; T Grodzicker
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

5.  Cellular uptake of the tat protein from human immunodeficiency virus.

Authors:  A D Frankel; C O Pabo
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.

Authors:  K A Jones; P A Luciw; N Duchange
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

7.  Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells.

Authors:  H Duclos; E Elfassi; S Michelson; F Arenzana-Seisdedos; U Hazan; A Munier; J L Virelizier
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

8.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.

Authors:  E Seto; T S Yen; B M Peterlin; J H Ou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.

Authors:  F K Wu; J A Garcia; D Harrich; R B Gaynor
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  8 in total

1.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

2.  The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription.

Authors:  Masanori Kameoka; Max Morgan; Marc Binette; Rodney S Russell; Liwei Rong; Xiaofeng Guo; Andrew Mouland; Lawrence Kleiman; Chen Liang; Mark A Wainberg
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.

Authors:  Pejman Rahimian; Johnny J He
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 2.643

4.  Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions.

Authors:  M T Browning; R D Schmidt; K A Lew; T A Rizvi
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.

Authors:  M O Westendorp; M Li-Weber; R W Frank; P H Krammer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.

Authors:  S L Schafer; J Vlach; P M Pitha
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

7.  The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.

Authors:  Y S Kim; A T Panganiban
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.

Authors:  G Scala; M R Ruocco; C Ambrosino; M Mallardo; V Giordano; F Baldassarre; E Dragonetti; I Quinto; S Venuta
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.